Negotiate Your Best Deal with Pharma Deals Intelligence
Evaluate life sciences biopharma deals to identify the best partners, strengthen negotiations, and drive company growth. Access comprehensive pharma deals intelligence to assess comparable deal terms, evaluate financials, and conduct thorough due diligence for in- or out-licensing opportunities.
Confidently pinpoint the best-fit partners by analyzing past pharma deals and current pipelines. Connect with experienced industry innovators and leaders to successfully develop and commercialize your assets.
Perform thorough due diligence for potential partnerships or M&A opportunities using critical data to understand biopharma deal structures, financials, contracts, and more.
Craft the optimal deal by leveraging data and insights to benchmark assets, forecast performance, and confidently prepare for negotiations.
Stay ahead of emerging competitors and pharma licensing opportunities with comprehensive coverage of early-phase assets and the start-up companies behind them.
Utilize our AI-based predictive deals analytics tool to forecast deal values and success, offering more accurate insights than conventional averages-based benchmarking.
Quickly generate deal activity and due diligence reports for internal or partnering meetings, using key deal trends graphs for impactful visualizations.
Identify in-licensing opportunities by defining your ideal candidate’s characteristics, or discover potential out-licensing partners based on their experience in the field and portfolio gaps. Dive deeper into potential partners’ deal history, including payment terms, to ensure the best fit.
Customized solutions, powered by extensive expertise in drug commercialization and healthcare, to strengthen your strategy and drive success.
Design & Developed with ❤ by Byte-io